Behrendt , S , Wittchen , H-U , Höfler , M , Lieb , R and Beesdo , K ( 2009 ) Transitions from first substance use to substance use disorders in adolescence: is early onset associated with a rapid escalation? Drug and Alcohol Dependence 99 , 68 – 78 .

Brunt , TM , van Laar , M , Niesink , RJ and van den Brink , W ( 2010 ) The relationship of quality and price of the psychostimulants cocaine and amphetamine with health care outcomes . Drug and Alcohol Dependence 111 , 21 – 29 .

Cascini , F , Aiello , C and Di Tanna , G ( 2012 ) Increasing delta-9-tetrahydrocannabinol (Δ−9-THC) content in herbal cannabis over time: systematic review and meta-analysis . Current Drug Abuse Reviews 5 , 32 – 40 .

Chan , GC , Hall , W , Freeman , TP , Ferris , J , Kelly , AB and Winstock , A ( 2017 ) User characteristics and effect profile of Butane Hash Oil: an extremely high-potency cannabis concentrate . Drug and Alcohol Dependence 178 , 32 – 38 .

Colizzi , M and Bhattacharyya , S ( 2017 ) Does cannabis composition matter? Differential effects of delta-9-tetrahydrocannabinol and cannabidiol on human cognition . Current Addiction Reports 4 , 62 – 74 .

Courtney , KE , Mejia , MH and Jacobus , J ( 2017 ) Longitudinal studies on the etiology of cannabis use disorder: a review . Current Addiction Reports 4 , 43 – 52 .

Curran , HV , Freeman , TP , Mokrysz , C , Lewis , DA , Morgan , CJ and Parsons , LH ( 2016 ) Keep off the grass? Cannabis, cognition and addiction . Nature Reviews Neuroscience 17 , 293 – 306 .

Di Forti , M , Marconi , A , Carra , E , Fraietta , S , Trotta , A , Bonomo , M et al. ( 2015 ) Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study . The Lancet Psychiatry 2 , 233 – 238 .

D'Souza , DC , Ranganathan , M , Braley , G , Gueorguieva , R , Zimolo , Z , Cooper , T et al. ( 2008 ) Blunted psychotomimetic and amnestic effects of Δ−9-tetrahydrocannabinol in frequent users of cannabis . Neuropsychopharmacology 33 , 2505 – 2516 .

ElSohly , MA , Mehmedic , Z , Foster , S , Gon , C , Chandra , S and Church , JC ( 2016 ) Changes in cannabis potency over the last 2 decades (1995–2014): analysis of current data in the United States . Biological Psychiatry 79 , 613 – 619 .

EMCDDA ( 2014 ) Report to the EMCDDA by the Reitox National Focal Point. The Netherlands Drug Situation 2014 . Luxembourg : Publications Office of the European Union .

EMCDDA ( 2016 ) European Drug Report: Trends and Developments . Luxembourg : Publications Office of the European Union .

Englund , A , Freeman , TP , Murray , RM and McGuire , P ( 2017 ) Can we make cannabis safer? The Lancet Psychiatry 4 , 643 – 648 .

Freeman , T and Winstock , A ( 2015 ) Examining the profile of high-potency cannabis and its association with severity of cannabis dependence . Psychological Medicine 45 , 3181 – 3189 .

Freeman , TP , Morgan , CJA , Hindocha , C , Schafer , GL , Das , RK and Curran , HV ( 2014 ) Just say ‘know’: how do cannabinoid concentrations influence users’ estimates of cannabis potency and the amount they roll in joints? Addiction 109 , 1686 – 1694 .

Freeman , TP and Swift , W ( 2016 ) Cannabis potency: the need for global monitoring . Addiction 111 , 376 – 377 .

McLaren , J , Swift , W , Dillon , P and Allsop , S ( 2008 ) Cannabis potency and contamination: a review of the literature . Addiction 103 , 1100 – 1109 .

Meier , MH ( 2017 ) Associations between butane hash oil use and cannabis-related problems . Drug and Alcohol Dependence 179 , 25 – 31 .

Mokrysz , C , Freeman , T , Korkki , S , Griffiths , K and Curran , H ( 2016 ) Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males . Translational Psychiatry 6 , e961 .

Monaghan , M , Hamilton , I , Lloyd , C and Paton , K ( 2016 ) Cannabis matters? Treatment responses to increasing cannabis presentations in addiction services in England . Drugs: Education, Prevention and Policy 23 , 54 – 61 .

Monshouwer , K , Van Laar , M and Vollebergh , WA ( 2011 ) Buying cannabis in ‘coffee shops’ . Drug and Alcohol Review 30 , 148 – 156 .

Montanari , L , Guarita , B , Mounteney , J , Zipfel , N and Simon , R ( 2017 ) Cannabis use among people entering drug treatment in Europe: a growing phenomenon? European Addiction Research 23 , 113 .

NDTMS ( 2014 ) Adult Drug Statistics from the National Drug Treatment Monitoring System (NDTMS) .

Nguyen , H and Reuter , P ( 2012 ) How risky is marijuana possession? Considering the role of age, race, and gender . Crime & Delinquency 58 , 879 – 910 .

Niesink , RJ , Rigter , S , Koeter , MW and Brunt , TM ( 2015 ) Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005–15 . Addiction 110 , 1941 – 1950 .

Pijlman , F , Rigter , S , Hoek , J , Goldschmidt , H and Niesink , R ( 2005 ) Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops . Addiction Biology 10 , 171 – 180 .

Potter , DJ , Clark , P and Brown , MB ( 2008 ) Potency of Δ9–THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology . Journal of Forensic Sciences 53 , 90 – 94 .

Schoeler , T , Petros , N , Di Forti , M , Klamerus , E , Foglia , E , Ajnakina , O et al. ( 2016 ) Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study . The Lancet Psychiatry 3 , 947 – 953 .

Schubart , CD , Sommer , IE , van Gastel , WA , Goetgebuer , RL , Kahn , RS and Boks , MP ( 2011 ) Cannabis with high cannabidiol content is associated with fewer psychotic experiences . Schizophrenia Research 130 , 216 – 221 .

Sevigny , EL ( 2013 ) Is today's marijuana more potent simply because it's fresher? Drug Testing and Analysis 5 , 62 – 67 .

Silins , E , Horwood , LJ , Patton , GC , Fergusson , DM , Olsson , CA , Hutchinson , DM et al. ( 2014 ) Young adult sequelae of adolescent cannabis use: an integrative analysis . The Lancet Psychiatry 1 , 286 – 293 .

Smart , R , Caulkins , JP , Kilmer , B , Davenport , S and Midgette , G ( 2017 ) Variation in cannabis potency and prices in a newly-legal market: evidence from 30 million cannabis sales in Washington state . Addiction 112 , 2167 – 2177 .

Swift , W , Wong , A , Li , KM , Arnold , JC and McGregor , IS ( 2013 ) Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile . PLoS ONE 8 , e70052 .

UNODC ( 2016 ) United Nations Office on Drugs and Crime, World Drug Report 2016 (United Nations publication, Sales No. E.16.XI.7).

van der Pol , P , Liebregts , N , Brunt , T , Amsterdam , J , Graaf , R , Korf , DJ et al. ( 2014 ) Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study . Addiction 109 , 1101 – 1109 .

van der Pol , P , Liebregts , N , de Graaf , R , Korf , DJ , van den Brink , W and van Laar , M ( 2013a ) Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study . Drug and Alcohol Dependence 133 , 352 – 359 .

van der Pol , P , Liebregts , N , Graaf , R , Have , M , Korf , DJ , Brink , W et al. ( 2013b ) Mental health differences between frequent cannabis users with and without dependence and the general population . Addiction 108 , 1459 – 1469 .

Van Laar , M , Van Der Pol , P and Niesink , R ( 2016 ) Limitations to the Dutch cannabis toleration policy: assumptions underlying the reclassification of cannabis above 15% THC . International Journal of Drug Policy 34 , 58 – 64 .

Wisselink , DJ , Kuijpers , WGT and Mol , A ( 2016 ) Key Figures Addiction Care 2015 . Houten : Stichting Informatie Voorziening Zorg .